Comparing comparators: a look at control arms in kidney cancer studies over the years

S Bracarda1, C Porta2, M Sisani1

  • 1Department of Medical Oncology, Ospedale San Donato, Istituto Toscano Tumori, Arezzo, Italy.

British Journal of Cancer
|November 7, 2014
PubMed

Insights

Recent clinical trials for advanced renal cell carcinoma yielded unexpected results. A thorough analysis of control arms and patient characteristics is crucial for understanding targeted therapy effectiveness.

Area of Science:

  • Oncology
  • Clinical Trials
  • Pharmacology

Background:

  • Advanced renal cell carcinoma (RCC) treatment has seen numerous positive randomized clinical trials in the last decade.
  • These trials primarily compared new drugs against interferon alpha-2a or sorafenib as active controls.
  • Some trial outcomes deviated from predictions, necessitating further investigation into underlying reasons.

Purpose of the Study:

  • To critically analyze completed randomized clinical trials for advanced RCC.
  • To evaluate the role and validity of interferon alpha-2a and sorafenib as control arms in these trials.
  • To identify factors influencing trial results for optimal use of targeted agents.

Main Methods:

  • Review of recently completed randomized clinical trials in advanced RCC.
  • Analysis of study designs comparing experimental drugs against specific active control arms (interferon alpha-2a, sorafenib).
  • Examination of patient baseline characteristics and other relevant factors within trial data.

Main Results:

  • Some trials did not produce expected results, indicating a need for deeper analysis.
  • The effectiveness of control arms in reflecting true treatment efficacy requires scrutiny.
  • Variations in patient populations and other factors may impact observed outcomes.

Conclusions:

  • A comprehensive review of advanced RCC trials is essential.
  • The validity and selection of control arms significantly influence study interpretation.
  • Understanding patient characteristics is key to optimizing the use of targeted therapies in advanced RCC.

Related Concept Videos

Imaging Studies I: Kidney, Ureter, and Bladder Studies01:28

Imaging Studies I: Kidney, Ureter, and Bladder Studies

Kidney, Ureter, and Bladder (KUB) StudiesKidney, Ureter, and Bladder (KUB) studies are standard diagnostic imaging procedures used to assess the anatomy of the urinary system. They are commonly utilized for patients experiencing abdominal pain or urinary symptoms. By using a simple X-ray of the abdomen, KUB studies can reveal structural and pathological abnormalities within the kidneys, ureters, and bladder. These studies are particularly valuable in diagnosing kidney stones, urinary...
807
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
880
Blood and Nerve Supply to the Kidney01:18

Blood and Nerve Supply to the Kidney

The kidneys are vital organs responsible for filtering and cleaning blood, removing waste products, and regulating electrolyte levels. To perform these essential functions, they require a constant and robust blood supply.
Bloody Supply to the Kidneys:
The kidneys receive their blood supply from the renal arteries, which branch off from the abdominal aorta—the main artery supplying the abdomen and lower body. The renal arteries enter the kidneys at the hilum, a notch on the medial side of...
6.2K
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
786
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
662